| Trial ID: | L3540 |
| Source ID: | NCT01087567
|
| Associated Drug: |
Intensive Insulin
|
| Title: |
INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
|
| Acronym: |
INSPIRE
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Intensive insulin|DRUG: Routine Care
|
| Outcome Measures: |
Primary: The need for rescue therapy, at 3 months|The need for rescue therapy, at 6 months|The need for rescue therapy, at 9 months|The need for rescue therapy, at 12 months | Secondary: A1c,C-peptide. Time to normoglycemia and rescue therapy. Mean glucose, mean FBG, HOMA-B, HOMA-IR. Hypoglycemic events (minor and major. Tolerability based on side effects., 3 months, 6 months, 9 months, 12 months
|
| Sponsor/Collaborators: |
Sponsor: Ohio University | Collaborators: Western University of Health Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
23
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-07
|
| Completion Date: |
2014-01
|
| Results First Posted: |
|
| Last Update Posted: |
2014-04-21
|
| Locations: |
Ohio University, Athens, Ohio, 45701, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01087567
|
